Qi Tang

Qi Tang is a Postdoctoral Associate at the RNA Therapeutics Institute and Department of Dermatology, UMass Chan Medical School, co-mentored by Dr. Anastasia Khvorova and Dr. John E Harris (Chair of Dermatology) on RNAi drug development for inflammatory skin diseases. He received his PhD in Pharmaceutical Sciences from the University of Rhode Island in 2019, focusing on nucleic acid chemical biology.

Education:

• PhD in Pharmaceutical Sciences, University of Rhode Island, 2019

His research centers on chemically engineered therapeutic RNAs, bridging nucleic acid chemistry and dermatology to innovate RNA-based medicines. Specializing in RNA interference (RNAi) mechanisms, he targets inflammatory skin conditions through novel drug design and nucleic acid modification strategies.

Scientific Awards:

• 2023 K99/R00 NIH Pathway to Independence Award (National Institute of Arthritis and Musculoskeletal and Skin Diseases)

Supported by the NIH Pathway to Independence Award, Dr. Tang is transitioning to an independent investigator role with plans to establish his own laboratory at UMass Chan Medical School in 2025. His current work integrates interdisciplinary mentorship to advance RNAi therapeutics from bench to clinical applications.

He operates within the collaborative ecosystem of the Khvorova lab and Department of Dermatology, leveraging institutional resources in RNA biology and skin disease research to develop targeted RNAi treatments for inflammatory disorders.